Literature DB >> 27744032

Novel morphology change of Au-Methotrexate conjugates: From nanochains to discrete nanoparticles.

Wei-Yuan Wang1, Xiu-Fen Zhao1, Xiao-Han Ju1, Yu Wang1, Lin Wang1, Shu-Ping Li2, Xiao-Dong Li1.   

Abstract

A novel morphology change of Au-methotrexate (Au-MTX) conjugates that could transform from nanochains to discrete nanoparticles was achieved by a simple, one-pot, and hydrothermal growth method. Herein, MTX was used efficiently as a complex-forming agent, reducing agent, capping agent, and importantly a targeting anticancer drug. The formation mechanism suggested a similarity with the molecular imprinting technology. The Au-MTX complex induced the MTX molecules to selectively adsorb on different crystal facets of gold nanoparticles (AuNPs) and then formed gold nanospheres. Moreover, the abundantly binding MTX molecules promoted directional alignment of these gold nanospheres to further form nanochains. More interestingly, the linear structures gradually changed into discrete nanoparticles by adding different amount of ethylene diamine tetra (methylene phosphonic acid) (EDTMPA) into the initial reaction solution, which likely arose from the strong electrostatic effect of the negatively charged phosphonic acid groups. Compared with the as-prepared nanochains, the resultant discrete nanoparticles showed almost equal drug loading capacity but with higher drug release control, colloidal stability, and in vitro anticancer activity. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anticancer drug; Discrete nanoparticles; Gold; Methotrexate; Nanochains

Mesh:

Substances:

Year:  2016        PMID: 27744032     DOI: 10.1016/j.ijpharm.2016.10.022

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  1 in total

1.  Methotrexate Gold Nanocarriers: Loading and Release Study: Its Activity in Colon and Lung Cancer Cells.

Authors:  Beatriz Álvarez-González; Marisa Rozalen; María Fernández-Perales; Miguel A Álvarez; Manuel Sánchez-Polo
Journal:  Molecules       Date:  2020-12-21       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.